Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Ainos Inc. | AIMD Ainos, Inc. | 13D/A | 17.97% | Aug 15, 2024 | 2y |
| MMCAP International Inc. SPC | CEP Cantor Equity Partners, Inc. Class A Ordinary Shares | 13G | 5.8% | Aug 14, 2024 | 2y |
| Thomist Capital Management, LP | BTU Peabody Energy Corp | 13D | 9.96% | Aug 13, 2024 | 2y |
| Ginkgo Bioworks, Inc. | BSLK Bolt Projects Holdings, Inc. | 13D | 8.5% | Aug 13, 2024 | 2y |
| Graham Holdings Co | PUBM PubMatic, Inc. | 13G | 5.7% | Aug 9, 2024 | 2y |
| SPHERA FUNDS MANAGEMENT LTD. | CMMB Chemomab Therapeutics Ltd. | 13G | 6.56% | Jul 25, 2024 | 2y |
| CENTILLION FUND, INC. | ENTX Entera Bio Ltd. | 13G/A | 6.7% | Jul 19, 2024 | 2y |
| Ayar Third Investment Company | LCID Lucid Group, Inc. | 13D/A | 65.97% | Mar 29, 2024 | 2y |
| Wood River Capital, LLC | ASPN Aspen Aerogels Inc | 13D/A | 15.93% | Aug 19, 2024 | 2y |
| Joseph R. Nerges | CSPI Csp Inc | 13D | 14.13% | Aug 19, 2024 | 2y |
| Galkin Vladimir | JBLU Jetblue Airways Corp | 13G/A | 8.6% | Aug 19, 2024 | 2y |
| Michael B. Chancellor | LIPO Lipella Pharmaceuticals Inc. | 13D/A | 18.8% | Aug 16, 2024 | 2y |
| BW Gestao de Investimentos Ltda. | CINT CI&T Inc | 13G/A | 10.3% | Aug 16, 2024 | 2y |
| Orin Hirschman | PSNL Personalis, Inc. | 13G/A | 6.7% | Aug 16, 2024 | 2y |
| Christopher Scott Ginieczki, as Personal Representative of the Estate of Geoffrey S. M. Hedrick | IA Innovative Solutions & Support Inc | 13D/A | 5.11% | Aug 16, 2024 | 2y |
| Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust | PROP Prairie Operating Co. | 13D/A | 49.9% | Aug 15, 2024 | 2y |
| AIR T INC | TULP Bloomia Holdings, Inc. | 13D/A | 27.5% | Aug 15, 2024 | 2y |
| Harraden Circle Investments, LLC | BUJA Bukit Jalil Global Acquisition 1 Ltd. Ordinary Shares | 13G | 5.05% | Aug 15, 2024 | 2y |
| BIOS FUND I, LP | ACTU Actuate Therapeutics, Inc. | 13D | 52.8% | Aug 14, 2024 | 2y |
| Windsor Private Capital LP | AIFF Firefly Neuroscience, Inc. | 13D | 21.3% | Aug 12, 2024 | 2y |
| Topline Capital Management, LLC | NRDS Nerdwallet, Inc. | 13G | 7.6% | Aug 9, 2024 | 2y |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | TBCH Turtle Beach Corp | 13G | 5.5% | Aug 9, 2024 | 2y |
| Beryl Capital Management LLC | CORZ Core Scientific, Inc. | 13G | 6% | Aug 9, 2024 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | TENX Tenax Therapeutics, Inc. | 13G | 9.99% | Aug 8, 2024 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | TENX Tenax Therapeutics, Inc. | 13G | 9.99% | Aug 8, 2024 | 2y |
| Beryl Capital Management LLC | GTHX G1 Therapeutics, Inc. Common Stock | 13G | 9.8% | Aug 7, 2024 | 2y |
| Kingdom Building, Inc. | AREB American Rebel Holdings Inc | 13D | 27.3% | Jul 24, 2024 | 2y |
| Bryant R. Riley | RILY BRC Group Holdings, Inc. | 13D/A | 23.2% | Aug 15, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | LEE LEE ENTERPRISES, Inc | 13D/A | 4.35% | Aug 15, 2024 | 2y |
| JEFF TOGHRAIE | AXIL Axil Brands, Inc. | 13D/A | 47.1% | Aug 15, 2024 | 2y |
| James A. Cacioppo | JUSH Jushi Holdings Inc. | 13D/A | 18.11% | Aug 14, 2024 | 2y |
| Prosight Management, LP | STTK Shattuck Labs, Inc. | 13G/A | 11.3% | Aug 14, 2024 | 2y |
| BIOGEN INC. | SGMOQ Sangamo Therapeutics, Inc | 13G/A | 1% | Aug 14, 2024 | 2y |
| Partners Group Private Equity (Master Fund), LLC | LTH Life Time Group Holdings, Inc. | 13D/A | 1.5% | Aug 14, 2024 | 2y |
| 22NW Fund, LP | FARM FARMER BROTHERS CO | 13D/A | 9.2% | Aug 14, 2024 | 2y |
| EcoR1 Capital, LLC | ANAB Anaptysbio, Inc | 13D/A | 25.8% | Aug 14, 2024 | 2y |
| Brehm Sean Michael | FCCN SPECTRAL CAPITAL Corp | 13D/A | 29.79% | Aug 14, 2024 | 2y |
| Insight Venture Partners X, L.P. | NCNO nCino, Inc. | 13D/A | 13.9% | Aug 14, 2024 | 2y |
| TPG GP A, LLC | LTH Life Time Group Holdings, Inc. | 13D/A | 19.3% | Aug 14, 2024 | 2y |
| Green LTF Holdings II LP | LTH Life Time Group Holdings, Inc. | 13D/A | 26.9% | Aug 14, 2024 | 2y |
| Gan Xiaochun | GDHG Golden Heaven Group Holdings Ltd. | 13D | 20.8% | Aug 13, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | SMP Standard Motor Products, Inc. | 13D | 3.03% | Aug 12, 2024 | 2y |
| Citius Pharmaceuticals, Inc. | CTOR Citius Oncology, Inc. | 13D | 92.6% | Aug 12, 2024 | 2y |
| STAR EQUITY FUND, LP | ENSV Enservco Corp. | 13D | 19.69% | Aug 9, 2024 | 2y |
| Tether Holdings Limited | AGRO Adecoagro S.A. | 13D | 9.8% | Aug 9, 2024 | 2y |
| Newtyn Management, LLC | TBPH Theravance Biopharma, Inc. | 13G | 8.4% | Aug 7, 2024 | 2y |
| Carbon Direct Capital Management LLC | LNZA LanzaTech Global, Inc. | 13G | 9.9% | Aug 6, 2024 | 2y |
| Eugene Nonko | MAX MediaAlpha, Inc. | 13D/A | 9.2% | Aug 2, 2024 | 2y |
| NORGES BANK | HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) | 13G/A | 0% | Jul 26, 2024 | 2y |
| Bin Zhao | HRGN Harvard Apparatus Regenerative Technology, Inc. | 13D/A | 25.9% | Jul 8, 2024 | 2y |